Aytu BioPharma Inc (AYTU)
1.54
-0.20
(-11.75%)
USD |
NASDAQ |
Nov 14, 16:00
1.54
0.00 (0.00%)
After-Hours: 16:59
Aytu BioPharma Max Drawdown (5Y): 100.00% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 100.00% |
| September 30, 2023 | 100.00% |
| August 31, 2023 | 100.00% |
| July 31, 2023 | 100.00% |
| June 30, 2023 | 100.00% |
| May 31, 2023 | 100.00% |
| April 30, 2023 | 100.00% |
| March 31, 2023 | 100.00% |
| February 28, 2023 | 100.00% |
| January 31, 2023 | 100.00% |
| December 31, 2022 | 100.00% |
| November 30, 2022 | 100.00% |
| October 31, 2022 | 100.00% |
| Date | Value |
|---|---|
| September 30, 2022 | 100.00% |
| August 31, 2022 | 100.00% |
| July 31, 2022 | 100.00% |
| June 30, 2022 | 100.00% |
| May 31, 2022 | 100.00% |
| April 30, 2022 | 100.00% |
| March 31, 2022 | 100.00% |
| February 28, 2022 | 100.00% |
| January 31, 2022 | 100.00% |
| December 31, 2021 | 100.00% |
| November 30, 2021 | 100.00% |
| October 31, 2021 | 100.00% |
| September 30, 2021 | 100.00% |
| August 31, 2021 | 100.00% |
| July 31, 2021 | 100.00% |
| June 30, 2021 | 100.00% |
| May 31, 2021 | 100.00% |
| April 30, 2021 | 100.00% |
| March 31, 2021 | 100.00% |
| February 28, 2021 | 100.00% |
| January 31, 2021 | 100.00% |
| December 31, 2020 | 100.00% |
| November 30, 2020 | 100.00% |
| October 31, 2020 | 100.00% |
| September 30, 2020 | 100.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
100.00%
Minimum
Nov 2019
100.00%
Maximum
Mar 2020
100.00%
Average
100.00%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
| enVVeno Medical Corp | 97.41% |
| Bristol-Myers Squibb Co | 47.67% |
| Telesis Bio Inc | -- |
| CEL-SCI Corp | 96.78% |
| AIM ImmunoTech Inc | 99.61% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -45.08 |
| Beta (5Y) | -1.396 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 109.5% |
| Historical Sharpe Ratio (5Y) | -0.5765 |
| Historical Sortino (5Y) | -1.548 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 32.70% |